Literature DB >> 18813945

CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.

Cordula Wessel1, Christina C Westhoff, Katharina Nowak, Ingrid Moll, Peter J Barth.   

Abstract

CD34(+) fibrocytes are constitutive elements of the human connective tissue. The stroma associated with invasive carcinomas is characterized by a stereotypic loss of CD34(+) fibrocytes and a phenotype change towards CD34(-) alpha-Smooth muscle actin (SMA)(+) myofibroblasts. Secreted protein acidic and rich in cysteine (SPARC) is an important mediator of tumor-associated stromal remodeling. Melanocytic lesions of the skin have not been investigated as to this aspect up to now. Thus, we investigated a total of 20 malignant melanomas and 29 melanocytic nevi. The normal dermis and benign melanocytic nevi showed numerous CD34(+) fibrocytes, whereas malignant melanomas were devoid of this cell type. alpha-SMA-positive myofibroblasts were absent from the normal dermis, melanocytic nevi, and malignant melanomas. SPARC was positive in malignant melanoma cells and negative in their associated stroma, while all melanocytic nevi were completely negative. The stromal phenotype of malignant melanomas (CD34(-) alpha-SMA(-)) differs from that of invasive carcinomas (CD34(-) alpha-SMA(+)) suggesting different pathogenic mechanisms involved in tumor-associated stromal remodeling. SPARC expression appears to be closely related to malignancy in melanocytic lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813945     DOI: 10.1007/s00428-008-0667-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

Review 1.  Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.

Authors:  C L Haycox; P B Odland; S M Olbricht; M Piepkorn
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

2.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  CD34 positive stromal cells in gastric adenocarcinomas.

Authors:  H Nakayama; H Enzan; E Miyazaki; N Kuroda; K Naruse; H Kiyoku; M Toi; M Hiroi
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

4.  CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.

Authors:  Wilhelm Nimphius; Roland Moll; Peter Olbert; Annette Ramaswamy; Peter J Barth
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

5.  Spindle cell predominant trichodiscoma: a fibrofolliculoma/trichodiscoma variant considered formerly to be a neurofollicular hamartoma: a clinicopathological and immunohistochemical analysis of 17 cases.

Authors:  Heinz Kutzner; Luis Requena; Arno Rütten; Thomas Mentzel
Journal:  Am J Dermatopathol       Date:  2006-02       Impact factor: 1.533

6.  Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma.

Authors:  H Nakayama; H Enzan; E Miyazaki; N Kuroda; K Naruse; M Hiroi
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

7.  Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.

Authors:  N Kuroda; Y-L Jin; T Hamauzu; M Toi; E Miyazaki; M Hiroi; T Moriki; H Enzan
Journal:  Histol Histopathol       Date:  2005-07       Impact factor: 2.303

8.  Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.

Authors:  J S Silverman; J Albukerk; A Tamsen
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

9.  CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.

Authors:  Peter J Barth; Schokufe Ebrahimsade; Achim Hellinger; Roland Moll; Annette Ramaswamy
Journal:  Virchows Arch       Date:  2002-02       Impact factor: 4.064

10.  CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.

Authors:  T T Kirchmann; V G Prieto; B R Smoller
Journal:  Arch Dermatol       Date:  1994-05
View more
  4 in total

Review 1.  Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Int J Biochem Cell Biol       Date:  2009-10-20       Impact factor: 5.085

2.  Malignant melanoma and its stromal nonimmune microecosystem.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  J Oncol       Date:  2012-06-28       Impact factor: 4.375

3.  CD34+ Stromal Cells/Telocytes as a Source of Cancer-Associated Fibroblasts (CAFs) in Invasive Lobular Carcinoma of the Breast.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Miriam González-Gómez; Maria Pino García; Lucio Díaz-Flores; José Luís Carrasco; Pablo Martín-Vasallo
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

4.  Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.

Authors:  Xavier Catteau; Philippe Simon; Michel Vanhaeverbeek; Jean-Christophe Noël
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.